Original paper

Survival and cost associated with chemotherapy and chemoradiotherapy among resected pancreas cancer patients.

Volume: 37, Issue: 4_suppl, Pages: 351 - 351
Published: Feb 1, 2019
Abstract
351 Background: Pancreas cancer is expensive to treat, and the effectiveness of adjuvant chemotherapy (CT) and chemoradiation (CRT) following resection is debated. We compared both survival and healthcare costs by adjuvant therapy after curative-intent pancreaticoduodenectomy (PD) for pancreas adenocarcinoma (PC). Methods: All patients with resected PC in Ontario, Canada diagnosed 2004 to 2014 were identified and linked to administrative...
Paper Details
Title
Survival and cost associated with chemotherapy and chemoradiotherapy among resected pancreas cancer patients.
Published Date
Feb 1, 2019
Volume
37
Issue
4_suppl
Pages
351 - 351
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.